Market Overview:
The Global Ambulatory Device Market size was valued at USD 6.07 billion in 2021 and is projected to register a valuation of USD 17.5 billion by 2030, at a Compound Annual Growth Rate CAGR of 15.5% over the forecast period 2022-2030. The rising incidence of the white coat effect during hospital pressure monitoring and growing demand for patient-friendly devices is driving the market revenue growth.
Ambulatory devices are any device that is designed to assist in walking and improve the mobility of people. Those who have difficulty in walking are people who cannot walk independently due to any trauma, injury, illness, or deformities. Some of the purposes of using the ability devices are to increase the area of support or base of support so that the patient will have a good balance when walking and they also be able to maintain the center of gravity over the supported area, and ambulatory devices redistribute weight-bearing area by decreasing force and injured or inflamed part of the body or the limb, and it also acts as a compensation for the weak muscles, and it decreases the pain by supporting the muscle groups.
Covid-19 Impact Analysis:
The outbreak of COVID-19 and the subsequent extent of the lockdown have impacted the ambulatory device market across the globe. As the Covid-19 crisis continues, many global industrial manufacturing companies are facing challenging times, including production shutdowns, transportation, supply chain disruptions, cost increases, and workforce disruptions, which negatively impact the global direct-to-ambulatory device industry in terms of revenue.
Driving Factors:
The widespread popularity of online-based shopping is a major driving factor in the market. An increase in preference for outpatient care and a reduction in hospital stay due to the emergence of minimally invasive surgeries will fuel market growth. Many medical treatments and ambulant help in preventive health care for chronic and acute diseases and illnesses.
The devices can be used anywhere at any time and can help perform minor surgical and medical procedures such as dermatology and dentistry. Support from NGOs is encouraging market demand. The high cost of related services, such as real-time tracking solutions, software upgrades, consumables, and accessories, will deter the market's growth.
Key Market Players:
- Abbott Laboratories
- BioTelemetry, Inc.
- Baxter International Inc.
- Becton, Dickinson and Company
- Boston Scientific Corporation
- CamNtech Ltd.
- Dimetek Digital Medical Technologies, Ltd.
- Cardiovascular Systems, Inc.
- Compumedics Limited
- Cadwell Industries, Inc.
- General Electric Company
- Halma plc (Parent Company)
- iRhythm Technologies, Inc.
- Mediblu Medical LLC
- Welch Allyn, Inc. (Subsidiary of Hill-Rom Holdings, Inc.)
- Mortara Instruments, Inc. (Subsidiary of Hill-Rom Holdings, Inc.)
- Vaso Corporation
- Meditech Ltd.
- Smiths Group plc
Market Segmentation:
The global ambulatory device market is segmented by product, by application, and region.
By Product
On the basis of product type, the market is segmented into Infusion Systems, Monitoring Devices, Recorders, and others.
Monitoring devices are used for disease and patient management. Wearable applications may influence clinical decision-making. This can enhance the quality of patient care while reducing the cost of care.
By Application
Based on application, the market is segmented into Outpatient Clinics, Hospitals, Ambulatory Surgical Centers, and others.
There are questions about the significant increase in the incidence of diseases of heart and hypertension. The support will boost the demand for the Outpatient Clinics segment to stimulate market growth.
Regional Analysis:
The global ambulatory device market is categorized into Latin America, North America, Europe, Asia-pacific, the Middle East, and Africa.
In terms of revenue, North America will dominate the market in 2021. Due to the well-developed healthcare industry and the presence of top key players in the market.
On the other hand, Asia-Pacific is projected to grow with the fastest CAGR during the forecast period. Due to rising investment in the healthcare sector and high hospital admission. The growth of the market in Asia-Pacific is driven by developing countries.
Report Coverage:
Market Segmentation:
By Product Type
- Infusion Systems
- Monitoring Devices
- Recorders
- Others
By Application
- Outpatient Clinics
- Hospitals
- Ambulatory Surgical Centers
- Others
By Region
North America-
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of Middle East and Africa